Tower Research Capital »

Eliem Therapeutics shares owned by Tower Research Capital

Quarter-by-quarter ownership of Eliem Therapeutics (ELYM) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Eliem Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eliem Therapeutics held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eliem Therapeutics by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $9.9k 3.6k 2.74
2023-09-30 $10k 3.9k 2.63
2023-06-30 $13k 4.8k 2.80
2023-03-31 $9.0k 3.3k 2.76
2022-12-31 $2.0k 642 3.12
2022-09-30 $3.0k 981 3.06
2022-06-30 $999 440 2.27
2022-03-31 $20k 2.4k 8.23
2021-12-31 $10k 1.0k 9.99
2021-09-30 $9.0k 491 18.33